Clinical Trial Page
Clinical Trial Results:
A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with combination therapy of LAF237 and pioglitazone to LAF237 monotherapy or pioglitazone monotherapy in drug naïve patients with type 2 diabetes
| Summary | |
EudraCT number | 2004-002940-82 |
Trial protocol | SK CZ GB IT |
Global completion date | 06 Jan 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 07 Jan 2017 |
First version publication date | 07 Jan 2017 |
Other versions | |
Summary report(s) | Summary of CLAF237A2355 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.